Year: 2025

SAIC Announces Fourth Quarter and Full Fiscal Year 2025 Results

Written by Customer Service on March 17, 2025. Posted in Dividend Reports And Estimates.

Q4 FY25 revenues of $1.84 billion, 5.8% organic growth(1); FY25 revenues of $7.48 billion, 3.1% organic growth(1); organic growth adjusted for divestitures Q4 FY25 net income of $98 million, adjusted EBITDA(1) of $177 million or 9.6% of revenue; FY25 net income of $362 million, adjusted EBITDA(1) of $710 million or 9.5% of revenue Q4 FY25 diluted earnings per share of $2.00, adjusted diluted earnings per share(1) of $2.57; FY25 diluted earnings per share of $7.17, adjusted diluted earnings per share(1) of $9.13 Q4 FY25 cash flows provided by operating activities of $115 million, free cash flow(1) and transaction-adjusted free cash flow(1) of $236 million; FY25 cash flows provided by operating activities of $494 million, free cash flow(1) of $499 million, transaction-adjusted free cash flow(1) of $507 million Q4 FY25 net bookings of $1.3...

Diversified Achieves Strong Final Year-End 2024 Results, Delivers on Capital Allocation Promises, and Introduces 2025 Combined Company Outlook

Written by Customer Service on March 17, 2025. Posted in Earnings Releases And Operating Results.

2024 Achievements Position Diversified on a Meaningful Path Forward as a Stronger and Larger Company Executed Approximately $2 Billion of Acquisitions in an Advantageous Pricing Environment Third year of Consistent Operating Costs Despite Broader Industry and Inflationary Pressures Maverick Integration Anticipated to Provide Meaningful Financial and Operational Benefits to Drive Free Cash Flow Acceleration Created a PDP Solution for Upstream Peers to Facilitate Operated Acquisitions with an Undeveloped Inventory Focus BIRMINGHAM, Ala., March 17, 2025 (GLOBE NEWSWIRE) — Diversified Energy Company PLC (LSE: DEC; NYSE: DEC) is pleased to announce its operational and final audited results for the year ended December 31, 2024. Diversified remains a differentiated key player in acquiring and building a portfolio of assets through value-accretive...

Belite Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Written by Customer Service on March 17, 2025. Posted in Earnings Releases And Operating Results.

Following a pre-specified interim analysis, the Data Safety Monitoring Board (DSMB) recommended the DRAGON trial, a pivotal Phase 3 trial in adolescent Stargardt 1 (STGD1) subjects, proceed without any modification; trial completion expected Q4 2025 (including a three-month follow-up period) Pivotal global Phase 3 PHOENIX trial of Tinlarebant in geographic atrophy (GA) subjects is ongoing with 406 subjects enrolled Raised $15 million in gross proceeds in a registered direct offering on February 5, 2025 Conference call and webcast on Monday, March 17, 2025, at 4:30 p.m. ETSAN DIEGO, March 17, 2025 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs,...

Townsquare Delivers Net Revenue and Adjusted EBITDA Growth in Q4 2024 Announces Increase in Dividend

Written by Customer Service on March 17, 2025. Posted in Earnings Releases And Operating Results.

Total Digital Net Revenue Growth of +10.8% in Q4 2024 Townsquare Ignite (Digital Advertising) Net Revenue Growth of +15.5% in Q4 2024 Repurchased $36 Million of Debt and $24 Million of Equity in 2024 Completed Debt Refinancing, Extending Maturities to 2030 PURCHASE, N.Y., March 17, 2025 (GLOBE NEWSWIRE) — Townsquare Media, Inc. (NYSE: TSQ) (“Townsquare,” the “Company,” “we,” “us,” or “our”) announced today its financial results for the fourth quarter and year ended December 31, 2024. “I am pleased to share that Townsquare’s performance improved meaningfully throughout 2024, culminating with fourth quarter net revenue growth of +2.6% year-over-year, and Adjusted EBITDA growth of +25.8% year-over-year, driven by the strong sequential improvement in our two digital businesses and the...

Dovre Group’s Financial Statement Release 1.1.–31.12.2024

Written by Customer Service on March 17, 2025. Posted in Earnings Releases And Operating Results.

DOVRE GROUP’S FINANCIAL STATEMENT RELEASE 1.1.–31.12.2024: The information presented in the report has not been audited. Dovre Group Plc Financial Statement Release March 17, 2025, at 12:15 pm Dovre Group Plc sold its entire Project Personnel business (PP) and Norwegian Consulting business to the Swedish NYAB AB on January 2, 2025. The deal was agreed conditionally on the authorization of the Dovre general meeting on November 20, 2024. The company’s extraordinary general meeting decided on December 16, 2024, in accordance with the board’s proposal, to approve the execution of the transaction, which took place on January 2, 2025. In this review, Dovre presents the sold operations as operations classified for sale and discontinued in accordance with the IFRS 5 standard. Previous profit and loss statements have...

Form 8.5 (EPT/RI) – Bakkavor Group Plc

Written by Customer Service on March 17, 2025. Posted in Mergers And Acquisitions.

FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Name of exempt principal trader: Shore Capital Stockbrokers Ltd(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Bakkavor Group Plc(c) Name of the party to the offer with which exempt principal trader is connected: Greencore Group Plc(d) Date dealing undertaken: 14 March 2025(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer? No2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER (a) Purchases and salesClass...

Niu Technologies Announces Unaudited Fourth Quarter and Full Year 2024 Financial Results

Written by Customer Service on March 17, 2025. Posted in Earnings Releases And Operating Results.

— Fourth Quarter Revenues of RMB 819.2 million, increase 71.1% year over year — Fourth Quarter Net Loss of RMB 72.5 million, compared to net loss of RMB 130.2 million in the same period of last year — Full Year Revenues of RMB 3,288.3 million, increase 24.0% year over year — Full Year Net loss of RMB 193.2 million, compared to net loss of RMB 271.8 million in 2023 BEIJING, March 17, 2025 (GLOBE NEWSWIRE) — Niu Technologies (“NIU”, or “the Company”) (NASDAQ: NIU), the world’s leading provider of smart urban mobility solutions, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Financial HighlightsRevenues were RMB 819.2 million, an increase of 71.1% year over year Gross margin was 12.4%, compared with 19.0% in the fourth quarter...

Final Results for the Year-Ended December 31, 2024

Written by Customer Service on March 17, 2025. Posted in Earnings Releases And Operating Results.

Diversified Achieves Strong Final Year-End 2024 Results, Delivers on Capital Allocation Promises, and Introduces 2025 Combined Company Outlook 2024 Achievements Position Diversified on a Meaningful Path Forward as a Stronger and Larger Company Executed Approximately $2 Billion of Acquisitions in an Advantageous Pricing Environment Third year of Consistent Operating Costs Despite Broader Industry and Inflationary Pressures Maverick Integration Anticipated to Provide Meaningful Financial and Operational Benefits to Drive Free Cash Flow Acceleration Created a PDP Solution for Upstream Peers to Facilitate Operated Acquisitions with an Undeveloped Inventory Focus BIRMINGHAM, Ala., March 17, 2025 (GLOBE NEWSWIRE) — Diversified Energy Company PLC (LSE: DEC; NYSE: DEC) is pleased to announce its operational and final audited results for...

Nexans enters into exclusive negotiations with Latour Capital for the sale of Lynxeo

Written by Customer Service on March 17, 2025. Posted in Mergers And Acquisitions.

Nexans enters into exclusive negotiations with Latour Capital for the sale of Lynxeo PRESS RELEASENexans announces having entered into exclusive negotiations with Latour Capital for the sale of Lynxeo for €525 million, subject to customary approvals With the proposed transaction, Nexans would achieve major step on its strategy to become a Pure Electrification PlayerParis, March 17th, 2025 – Nexans announces today having entered into exclusive negotiations for the sale of its industrial cable division Lynxeo to Latour Capital, a France-based private equity fund, for an Enterprise Value of €525 million. This proposed transaction would mark Nexans’ exit from the specialty industrial cables activity in line with its strategy to refocus as a Pure Electrification Player. Lynxeo is a powerhouse in specialty industrial cables and plays...

EsoBiotec to Be Acquired by AstraZeneca to Advance Cell Therapy Ambition

Written by Customer Service on March 17, 2025. Posted in Mergers And Acquisitions.

Acquisition includes EsoBiotec’s world-leading in vivo delivery platform with potential to transform cell therapy MONT-SAINT-GUIBERT, Belgium, March 17, 2025 (GLOBE NEWSWIRE) — EsoBiotec SA, a biotechnology company pioneering in vivo cell therapies that has demonstrated promising early clinical activity, today announced it has entered into a definitive agreement to be acquired by AstraZeneca (LSE/STO/Nasdaq: AZN). The EsoBiotec Engineered NanoBody Lentiviral (ENaBL) platform empowers the immune system to attack cancers and could offer many more patients access to transformative cell therapy treatments delivered in just minutes rather than the current process which takes weeks. ENaBL uses highly targeted lentiviruses to deliver genetic instructions to specific immune cells, such as T cells, which programme them to recognise and...

Year: 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals